Establish a specialized government fund for cannabis-based medicinal products
Target Beneficiaries
People with treatment-resistant epilepsy across the UK
Current Challenge
Unaffordable costs reaching thousands of pounds monthly
Our mission focuses on ensuring that effective seizure control treatments are accessible based on medical need rather than financial means.
Website Coming Soon
Launch Timeline
Our comprehensive website will be launching soon with complete campaign information
Forthcoming Content
Detailed campaign goals and proposed eligibility criteria for the medicines access fund
Support Options
Ways to get involved and help advance this critical healthcare initiative
About This Campaign
Medical Specialists
Epilepsy treatment experts providing clinical guidance and evidence-based recommendations
Patient Advocates
People with lived experience of treatment-resistant epilepsy sharing crucial perspectives
Advocacy Organisations
Established epilepsy research and support groups lending expertise and resources
Policy Advisors
Healthcare policy experts helping craft viable government funding proposals
For More Information
Speak With Your Specialist
If you're currently receiving cannabis-based medicines for epilepsy, your prescribing specialist can provide campaign information and discuss potential benefits.
Healthcare Provider Updates
Medical professionals are being regularly briefed on campaign developments to support patient conversations about this initiative.
Stay Connected
Our upcoming website will provide additional contact methods and resources for both patients and medical practitioners.
Privacy Notice
Current Data Collection
This website does not currently collect or store any personal information from visitors. Your privacy is fully protected whilst browsing our interim page.
Future Privacy Practices
When our complete website launches, we will implement comprehensive data protection measures in full compliance with UK regulations and best practices.
Your Privacy Rights
We respect your right to control your personal information and will provide clear options regarding data collection when our full site is available.